Showing results (121-130 of 204) with videos related to
Sort By:
Pageof 21
The Journal of Dermatology|December 13, 2019
Cutaneous fusariosis caused by Fusarium lichenicola in a child with hyper-immunoglobulin E syndromeMinglan Shi, Sha Lu, Jiahao Li, et al.Mycoses|February 14, 2026
Rapid Detection of Fungi in Nail Specimens Using Multi-Tube Recombinase Polymerase Amplification AssayRong Wu, Meirong Li, Weian Du, et al.Sexual Health|January 8, 2026
An Improved Method for Recovering Clinical Isolates and Assessing Pathogenicity of Blood from Secondary SyphilisXiaohui Zhang, Yinbo Jiang, Litian Zhang, et al.Annals of Clinical Microbiology and Antimicrobials|September 12, 2024
Retrospective clinical and microbiologic analysis of metagenomic next-generation sequencing in the microbiological diagnosis of cutaneous infectious granulomasHsingmei Liu, Qiao Ran, Jianchi Ma, et al.Mycoses|August 8, 2023
Combination therapy with itraconazole and terbinafine for phaeohyphomycosis caused by Exophiala spinifera: A case report and literature reviewXianzhong Zhu, Jianchi Ma, Bowen Zheng, et al.European Journal of Dermatology : EJD|August 26, 2011
In vitro activity of itraconazole in combination with terbinafine against clinical strains of itraconazole-insensitive Sporothrix schenckiiXiaohui Zhang, Huaiqiu Huang, Peiying Feng, et al.Microbiological Research|December 28, 2020
Deletion of pksA attenuates the melanogenesis, growth and sporulation ability and causes increased sensitivity to stress response and antifungal drugs in the human pathogenic fungus Fonsecaea monophoraXing Xiao, Yu Li, Yu Lan, et al.Plos Neglected Tropical Diseases|April 16, 2026
Correction: Calcineurin regulates morphological development, stress responses and virulence in Fonsecaea monophoraMinying Li, Huan Huang, Dongmei Li, et al.Advances in Therapy|November 13, 2024
Efficacy and Safety Analysis in Chinese Patients with Moderate-to-Severe Psoriasis from a Phase 3 Trial: Impact of Treatment Withdrawal and Retreatment of IxekizumabXinghua Gao, Weili Pan, Min Zheng, et al.Advances in Therapy|September 30, 2024
Efficacy of Ixekizumab in Chinese Patients with Moderate-to-Severe Psoriasis and Special Body Area Involvement: Sub-analysis of a Randomized, Double-Blind, Multicenter Phase 3 StudyXia Li, Yangfeng Ding, Chunlei Zhang, et al.Pageof 21